HuagongsheHuagongshe Chemistry Print Report · For research reference only
6-Bromo-4-{4-[4-(methylsulfonyl)phenoxy]piperidino}quinoline → 4-[4-(4-methylsulfonylphenoxy)piperidin-1-yl]-6-(3-trifluoromethyl-1-trityl-1H-pyrazol-4-yl) quinoline
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 6-Bromo-4-{4-[4-(methylsulfonyl)phenoxy]piperidino}quinoline | HCID 22031182 | — |
| Reactant | [3-(Trifluoromethyl)-1-trityl-1H-pyrazol-4-YL]boronic acid | HCID 22032227 | — |
| Product | 4-[4-(4-methylsulfonylphenoxy)piperidin-1-yl]-6-(3-trifluoromethyl-1-trityl-1H-pyrazol-4-yl) quinoline | HCID 68814068 | 98.9% |
Reaction Steps
150 mg 6-bromo-4-{4-[4-(methylsulfonyl)phenoxy]piperidino}quinoline (compound in Production Example 89) and 180 mg 3-trifluoromethyl-1-trityl-1H-4-pyrazolylboronic acid (compound in Production Example 31) were reacted in the same manner as in Example 9, to give 244 mg 4-[4-(4-methylsulfonylphenoxy)piperidin-1-yl]-6-(3-trifluoromethyl-1-trityl-1H-pyrazol-4-yl) quinoline. This product was reacted in the same manner as in Example 67, to give 130 mg of the title compound as pale yellow crystals.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07074801B1 |
| Source dataset | uspto-grants-2006_07 |
| ORD ID | ord-d3ecdb12e6c848a6abe3d00d7327c16f |
| Source note | uspto-grants-2006_07 |